|
[1] McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis [J]. J Clin Gastroenteml, 2006, 40 (Suppl 1) : S17-S 29.
|
|
[2]Jenkins CM, Mancuso DJ, Yan W, et al.Identification, clo-ning, expression, and purification of three novel human calci-um-independent phospholipase A2familymembers possess-ing triacylglycerol lipase and acylglycerol transacylase activities[J].J Biol Chem, 2004, 279 (47) :48968-48975.
|
|
[3] He S, McPhaul C, Li JZ, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis [J].J Biol Chem, 2010, 285 (9) : 6706-6715.
|
|
[4]Kershaw EE, Hamm JK, Verhagen LA, et al.Adipose triglyc-eride lipase:function, regulation by insulin, and comparison with adiponutrin[J].Diabetes, 2006, 55:148-157.
|
|
[5]Villena JA, Roy S, Sarkadi-Nagy E, et al.Desnutrin, an adi-pocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids:ectopic ex-pression of desnutrin increases triglyceride hydrolysis[J].J Biol Chem, 2004, 279 (45) :47066-47075.
|
|
[6]Lake AC, Sun Y, Li JL, et al.Expression, regulation, and tri-glyceride hydrolase activity of Adiponutrin family members[J].J Lip id Res, 2005, 46 (11) :2477-2487.
|
|
[7]Romeo S, Huang-Doran I, Baroni MG, et al.Unravelling the pathogenesis of fatty liver disease:patatin-like phos-pholipase domain-containing3protein[J].Curr Opin Lipi-dol, 2010, 21 (3) :247-252.
|
|
[8] Chen W, Chang B, Li L, et al. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease[J].Hepatology, 2010 , 52 (3) : 1134-1142.
|
|
[9] Hoekstra M, Li Z, Kruijt JK, et al. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status[J]. J Hepatol, 2010 , 52 (2) : 244-251.
|
|
[10] Wilson PA, Gardner SD, Lambie NM, et al. Characterization of the human patatin-like phospholipase family[J]. J Lipid Res, 2006, 47 (9) : 1940-1949.
|
|
[11] Liu YM, Moldes M, Bastard JP, et al. Adiponutrin: a new gene regulated by energy balance in human adipose tissue[J]. J Clin Endocrinol Metab, 2004, 89 (6) : 2684-2689.
|
|
[12] Moldes M, Beauregard G, Faraj M, et al. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue[J]. Eur J Endocrinol, 2006, 155 (3) : 461-468.
|
|
[13]Kotronen A, Johansson LE, Johansson LM, et al.A com-mon variant in PNPLA3, which encodes adiponutrin, is asso-ciated with liver fat content in humans[J].Diabetologia, 2009, 52 (6) :1056-1060.
|
|
[14]Petersen KF, Dufour S, Feng J, et al.Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asi-an–Indian men[J].Proc Natl Acad Sci U S A, 2006, 103 (48) :18273-18277.
|
|
[15] Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity[J]. Hepatology, 2004, 40 (6) : 1387-1395.
|
|
[16]Romeo S, Kozlitina J, Xing C, et al.Genetic variation in PNPLA3confers susceptibility to nonalcoholic fatty liver dis-ease[J].Nat Genet, 2008, 40 (12) , 40:1461-1465.
|
|
[17]Sookoian S, Gustavo GO, Burgue no AL, et al.A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity[J].J Lipid Res, 2009, 50 (10) :2111-2116.
|
|
[18]Kantartzis K, Peter A, Machicao F, et al.Dissociation be-tween fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase3gene[J].Diabe-tes, 2009, 58 (11) :2616-2623.
|
|
[19] Yuan X, Waterworth D, Perry JR, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes[J]. Am J Hum Genet, 2008, 83 (4) : 520-528.
|
|
[20] Speliotes EK, Butler JL, Palmer CD, et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease[J]. Hepatology, 2010, 52 (3) : 904-912.
|
|
[21]Romeo S, Sentinelli F, Dash S, et al.Morbid obesity expo-ses the association between PNPLA3I148M (rs738409) and indices of hepatic injury in individuals of European descent[J].Int J Obes (Lond) , 2010, 34 (1) :190-194.
|
|
[22]Valenti L, Al-Serri A, Daly AK, et al.Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fi-brosis in patients with nonalcoholic fatty liver disease[J].Hepatology, 2010, 51 (4) :1209-1217.
|
|
[23]Krawczyk M, Grünhage F, Zimmer V, et al.Variant adiponu-trin (PNPLA3) represents a common fibrosis risk gene:non-invasive elastography-based study in chronic liver disease[J].J Hepatology, 2011, 55 (2) :299-306.
|
|
[24]Romeo S, Sentinelli F, Cambuli VM, et al.The148M allele of the PNPLA3gene is associated with indices of liver dam-age early in life[J].J Hepatol, 2010, 53 (2) :335-338.
|
|
[25]Valenti L, Alisi A, Galmozzi E, et al.I148M patatin-like phospholipase domain-containing3gene variant and severi-ty of pediatric nonalcoholic fatty liver disease[J].Hepatolo-gy, 2010, 52 (4) :1274-1280.
|
|
[26] Johansson LE, Lindblad U, Larsson CA, et al. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity[J]. Eur J Endocrinol, 2008, 159 (5) : 577-583.
|
|
[27] Johansson LE, Johansson LM, Danielsson P, et al. Genetic variance in the adiponutrin gene family and childhood obesity[J]. PLoS One, 2009, 4 (4) : e5327.
|
|
[28]Liang H, Cai M, Bi Y, et al.A single nucleotide polymor-phism (SNP) rs2072907in the adiponutrin gene (ADPN) was not associated with obesity and type2diabetes in Chi-nese population[J].Diabetes Res Clin Pract, 2009, 85 (3) :e37-e39.
|
|
[29] Petit JM, Guiu B, Masson D, et al. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes[J]. J Clin Endocrinol Metab, 2010, 95 (12) : E430- E436.
|
|
[30]Chen W, Chang B, Li L, et al.Patatin-like phospholipase domain-containing3/adiponutrin deficiency in mice is not as-sociated with fatty liver disease[J].Hepatology, 2010, 52 (3) :1134-1142.
|
|
[31]Basantani MK, Sitnick MT, Cai L, et al.Pnpla3/Adiponutrin de-ficiency in mice does not contribute to fatty liver disease or met-abolic syndrome[J].J Lipid Res, 2011, 52 (2) :318-329.
|
DownLoad: